Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HOLLEBECQUE, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

Équipoise clinique et études cliniques randomisées en cancérologie = Clinical equipoise and randomised clinical trials in oncologyFERTE, C; HOLLEBECQUE, A; SALLERON, J et al.Bulletin du cancer. 2009, Vol 96, Num 6, pp 727-731, issn 0007-4551, 5 p.Article

Efficacy of phase 1 trials in malignant pleural mesothelioma: Description of a series of patients at a single institutionRAPHAEL, J; LE TEUFF, G; HOLLEBECQUE, A et al.Lung cancer. 2014, Vol 85, Num 2, pp 251-257, issn 0169-5002, 7 p.Article

A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphomaHOLLEBECQUE, A; DEUTSCH, E; VARGA, A et al.Investigational new drugs. 2013, Vol 31, Num 6, pp 1530-1538, issn 0167-6997, 9 p.Article

Low skeletal muscle is associated with toxicity in patients included in phase I trialsCOUSIN, Sophie; HOLLEBECQUE, A; KOSCIELNY, S et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 382-387, issn 0167-6997, 6 p.Article

Prise en charge des complications cardiovasculaires des traitements en oncologie thoracique = Management of the cardiovascular complications of treatment in thoracic oncologyEDERHY, S; HOLLEBECQUE, A; COHEN, A et al.Revue des maladies respiratoires. 2014, Vol 31, Num 2, pp 173-180, issn 0761-8425, 8 p.Article

Évaluation d'un programme de formation à la communication dans le cadre d'essais thérapeutiques de phase I selon l'expérience des oncologues : CANCERS ET COMMUNICATIONS = Evaluation of a Communication Training Programme within the Context of Phase I Therapeutic Studies According to the Experience of Oncologists : CANCERS AND COMMUNICATIONROUBY, P; HOLLEBECQUE, A; PHILIPPART, M et al.Psycho-oncologie. 2014, Vol 8, Num 4, pp 230-236, issn 1778-3798, 7 p.Article

Récepteurs nucléaires PPAR et hépatologie : implications physiopathologiques et thérapeutiques = Nuclear receptor PPAR and hepatology : Pathophysiological and therapeutical aspectsDHARANCY, S; LOUVET, A; HOLLEBECQUE, A et al.Gastroentérologie clinique et biologique. 2008, Vol 32, Num 3, pp 339-350, issn 0399-8320, 12 p., CAH1Article

Chimiothérapie des métastases d'origine colorectale jamais résécables: stratégie multiligne, thérapies ciblées = Chemotherapy for Previously Unresectable Colorectal Metastases: Multi-line Strategies and Targeted TherapiesBOIGE, V; MALKA, D; FERTE, C et al.Oncologie (Paris). 2014, Vol 16, Num 11-12, pp 579-586, issn 1292-3818, 8 p.Article

Bevacizumab-induced laryngeal necrosisHARTL, D. M; BAHLEDA, R; HOLLEBECQUE, A et al.Annals of oncology. 2012, Vol 23, Num 1, pp 276-278, issn 0923-7534, 3 p.Article

Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh scoreHOLLEBECQUE, A; CATTAN, S; HEBBAR, M et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 10, pp 1193-1201, issn 0269-2813, 9 p.Article

Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantationHOLLEBECQUE, A; DECAENS, T; BOLESLAWSKI, E et al.Gastroentérologie clinique et biologique. 2009, Vol 33, Num 5, pp 361-369, issn 0399-8320, 9 p.Article

  • Page / 1